IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R α and γ chains

[1]  P. Marrack,et al.  Cytokine-induced survival of activated T cells in vitro and in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Muñoz,et al.  Interleukin‐7 treatment promotes the differentiation pathway of T‐cell‐receptor‐αβ cells selectively to the CD8+ cell lineage , 1997, Immunology.

[3]  B. E. Rich.  Autocrine expression of interleukin‐7 rescues lymphoid expansion in interleukin‐7‐deficient mice , 1997, Immunology.

[4]  P. Marrack,et al.  Interleukin 4 (IL-4) or IL-7 Prevents the Death of Resting T Cells: Stat6 Is Probably Not Required for the Effect of IL-4 , 1997, The Journal of experimental medicine.

[5]  Yili Yang,et al.  Interleukin-2 and interleukin-7 augment the cytolytic activity and expand the antitumor killing spectrum of α CD3-induced activated killer cells: potential use in the immunotherapy of non-immunogenic tumors , 1997, Cancer Immunology, Immunotherapy.

[6]  A. Ramsay,et al.  Interleukin-7 enhances cell-mediated immune responses in vivo in an interleukin-2-dependent manner. , 1997, Viral immunology.

[7]  T. Tsuruo,et al.  Interleukin-7 inhibits apoptosis of mouse malignant T-lymphoma cells by both suppressing the CPP32-like protease activation and inducing the Bcl-2 expression. , 1996, Oncogene.

[8]  D. Bourdette,et al.  MHC‐restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR Vβ CDR2 peptides: Comparison with myelin basic protein‐specific T cells , 1996, Journal of neuroscience research.

[9]  A. Abbas,et al.  The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. , 1996, Immunity.

[10]  O. Igarashi,et al.  Early activation signal transduction pathways of Th1 and Th2 cell clones stimulated with anti-CD3. Roles of protein tyrosine kinases in the signal for IL-2 and IL-4 production. , 1995, Journal of immunology.

[11]  M. Armant,et al.  IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. , 1995, Immunology.

[12]  J. Siegel,et al.  Synergistic effects of IL-7 and IL-12 on human T cell activation. , 1995, Journal of immunology.

[13]  O. Silvennoinen,et al.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. , 1994, Science.

[14]  J. Gribben,et al.  Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. , 1994, Science.

[15]  J. Johnston,et al.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.

[16]  J. V. van Noort,et al.  Fractionation of central nervous system myelin proteins by reversed-phase high-performance liquid chromatography. , 1994, Journal of chromatography. B, Biomedical applications.

[17]  D. Bourdette,et al.  Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides. , 1994, Journal of immunology.

[18]  H. Weiner,et al.  Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis , 1994, The Journal of experimental medicine.

[19]  Robert E. Miller,et al.  Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo , 1994, The Journal of experimental medicine.

[20]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[21]  D. Bourdette,et al.  Episodic changes in T‐cell frequencies to myelin basic protein in patients with multiple sclerosis , 1993, Neurology.

[22]  K. Muegge,et al.  Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. , 1993, Science.

[23]  T. Taniguchi,et al.  The IL-2 IL-2 receptor system: A current overview , 1993, Cell.

[24]  N. Tanaka,et al.  Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.

[25]  D. Bourdette,et al.  Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.

[26]  D. Williams,et al.  The effects of interleukin 7 (IL-7) on human bone marrow in vitro. , 1991, Experimental hematology.

[27]  T. Olsson,et al.  Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls , 1991, European journal of immunology.

[28]  T. Olsson,et al.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. , 1990, The Journal of clinical investigation.

[29]  S. Reed,et al.  Regulation of T cell proliferation by IL-7. , 1990, Journal of immunology.

[30]  S. Dower,et al.  Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7- dependent cell line , 1990, The Journal of experimental medicine.

[31]  K. Grabstein,et al.  Regulation of human T cell proliferation by IL-7. , 1990, Journal of immunology.

[32]  N. Minato,et al.  IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing alpha beta or gamma delta T-cell receptors in vitro: synergism with IL-2. , 1989, Journal of immunology.

[33]  J. Watson,et al.  Effect of IL-7 on the growth of fetal thymocytes in culture. , 1989, Journal of immunology.

[34]  E. Shevach,et al.  Interleukin 7 is a T-cell growth factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Taniguchi,et al.  Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. , 1989, Science.

[36]  M. Feldmann,et al.  Interleukin 7 (murine pre‐B cell growth factor/lymphopoietin 1) stimulates thymocyte growth: regulation by transforming growth factor beta , 1989, European journal of immunology.

[37]  C. March,et al.  B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors , 1988, The Journal of experimental medicine.

[38]  E. Defreitas,et al.  Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Hashim,et al.  Biological activity of region 65–102 of the myelin basic protein , 1986, Journal of neuroscience research.

[40]  C. Taswell,et al.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.

[41]  F. Bach,et al.  Differential function of major histocompatibility complex antigens in T-lymphocyte activation , 1976, Nature.

[42]  W. Norton,et al.  MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION 1 , 1973, Journal of neurochemistry.